Hematologic, Immunologic, and Infection Supportive Care

Hematologic, Immunologic, and Infection Supportive Care

Cytopenias, Nadir Timing, and Risk Recognition

Most cytotoxic regimens injure bone marrow. The nadir (lowest blood-count point) typically occurs 7-14 days after treatment, with recovery by day 21-28, which is why the nurse always ties symptoms to the treatment day. Neutropenia raises infection risk, anemia reduces oxygen delivery, and thrombocytopenia raises bleeding risk. Interpret the absolute neutrophil count (ANC), hemoglobin, platelet count, and their trend, never a single value in isolation. Calculate ANC as: ANC = total WBC x (% segs + % bands) / 100. Classic severity bands appear on the exam:

A neutropenic patient may look well early in sepsis because few neutrophils mean few localizing signs of pus or redness. Teach patients to report any fever exactly as instructed, plus chills, rigors, cough, sore throat, dysuria, diarrhea, line redness, or confusion, and never to delay because the fever is low or because they already took acetaminophen.

Febrile Neutropenia: The High-Yield Emergency

Febrile neutropenia is defined as a single oral temperature of 38.3 C (101 F), or 38.0 C (100.4 F) sustained one hour, with an ANC below 500 cells/mcL (or expected to fall below it). It is an oncologic emergency. Priority sequence: rapid assessment and vitals, draw blood cultures (peripheral and from each lumen), then administer broad-spectrum empiric antibiotics, ideally within 60 minutes of presentation. Do not wait for the ANC to result before starting the pathway if risk is high.

Transfusion, Growth Factors, and Bleeding Support

Transfusions support symptomatic anemia or low platelets per ordered thresholds (often platelets transfused below ~10k prophylactically, or higher with bleeding or procedures). Nursing duties: verify the product with two clinicians, confirm consent, obtain baseline vitals, stay with the patient for the first 15 minutes, and monitor for reactions, fever, chills, back pain, dyspnea, hypotension, hives, or hemoglobinuria. If a reaction is suspected, stop the transfusion immediately, keep the line open with normal saline, and follow policy.

Growth factors include filgrastim and pegfilgrastim (neutrophils; expect bone pain) and erythropoiesis-stimulating agents for anemia. Bleeding precautions: soft toothbrush, electric razor, no rectal temps or suppositories when platelets are low, fall prevention, and clearance before aspirin, NSAIDs, supplements, or dental work.

Immune-Mediated Toxicities

Checkpoint inhibitors cause immune-related adverse events (irAEs): pneumonitis, colitis, hepatitis, dermatitis, endocrinopathies, nephritis, and myocarditis, often treated with corticosteroids. CAR-T and bispecific antibodies cause cytokine release syndrome (CRS) (fever, hypotension, hypoxia) and immune effector cell-associated neurotoxicity syndrome (ICANS) (tremor, aphasia, confusion, scored by ICE). Allogeneic transplant recipients develop graft-versus-host disease (GVHD) with rash, diarrhea, and liver abnormalities.

The OCN priority across all of these is early recognition and escalation, because immunosuppressed and lymphocyte-depleted patients may present with only weakness, confusion, or low appetite before obvious fever. Reassess after each intervention: did fever resolve, were cultures drawn before antibiotics, did the transfusion improve dyspnea, and does the patient understand the next fever plan?

Infection Prevention and Protective Measures

Prevention is as testable as treatment. Hand hygiene is the single most effective measure and is taught to patients, families, and staff. During profound neutropenia some centers add a neutropenic (low-microbial) diet or protective environment, but practices vary, so the nurse teaches the specific plan the oncology or transplant team ordered rather than generic restrictions. Common-sense teaching includes avoiding crowds and sick contacts, daily oral care with a soft brush, perineal hygiene, prompt skin and wound care, and avoiding gardening, pet waste, and standing water without protection.

Live vaccines are generally avoided during active immunosuppression, and the nurse confirms timing with the provider. Patients should not delay reporting any fever for any reason, including embarrassment, a low reading, or self-treatment with acetaminophen, which can mask the very sign the team needs.

Anemia and Thrombocytopenia in Daily Practice

Symptomatic anemia is managed by treating the cause, transfusing per threshold, and teaching energy conservation; the nurse advises changing positions slowly to limit orthostatic dizziness and reporting chest pain, marked dyspnea, or syncope, which suggest the heart is compensating poorly. Erythropoiesis-stimulating agents are used cautiously because of thrombosis and tumor-progression concerns and are not first-line for all anemia.

For thrombocytopenia, the nurse layers precautions to the count: routine caution below 100,000, active bleeding precautions below 50,000, and spontaneous-bleeding vigilance below 20,000, with platelet transfusion often considered prophylactically near 10,000 or earlier with fever or procedures. The nurse holds invasive procedures, avoids intramuscular injections when possible, applies prolonged pressure to puncture sites, and watches for the most dangerous bleed, intracranial hemorrhage, by checking for new severe headache, vision change, or altered mental status.

Connecting each precaution to its specific count and clinical trigger is exactly the reasoning OCN items test.